Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.16
0.032.65%
At close: -
$1.11
-0.05-4.31%
After Hours: 6:14 PM EDT
Comments
Loading...
Mural Oncology Analyst Ratings and Price Targets | NASDAQ:MURA | Benzinga
Mural Oncology PLC has a consensus price target of $13 based on the ratings of 5 analysts. The high is $18 issued by Raymond James on October 4, 2024. The low is $6 issued by HC Wainwright & Co. on March 26, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Jones Trading on March 26, 2025, March 12, 2025, and January 27, 2025, respectively. With an average price target of $13.33 between HC Wainwright & Co., HC Wainwright & Co., and Jones Trading, there's an implied 1101.20% upside for Mural Oncology PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Raymond James
Rodman & Renshaw
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Mural Oncology
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | Buy Now | 440.54% | HC Wainwright & Co. | Andres Maldonado40% | $18 → $6 | Maintains | Buy | Get Alert |
| 03/25/2025 | Buy Now | — | Jones Trading | Soumit Roy34% | — | Downgrade | Buy → Hold | Get Alert |
| 03/12/2025 | Buy Now | 1521.62% | HC Wainwright & Co. | Andres Maldonado40% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 01/27/2025 | Buy Now | 1341.44% | Jones Trading | Soumit Roy34% | → $16 | Initiates | → Buy | Get Alert |
| 11/14/2024 | Buy Now | 1521.62% | HC Wainwright & Co. | Andres Maldonado40% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/11/2024 | Buy Now | 1521.62% | HC Wainwright & Co. | Andres Maldonado40% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 10/17/2024 | Buy Now | 1521.62% | HC Wainwright & Co. | Andres Maldonado40% | → $18 | Initiates | → Buy | Get Alert |
| 10/04/2024 | Buy Now | 1521.62% | Raymond James | Laura Prendergast19% | → $18 | Initiates | → Strong Buy | Get Alert |
| 06/28/2024 | Buy Now | 1251.35% | Rodman & Renshaw | Tony Butler43% | → $15 | Initiates | → Buy | Get Alert |
| 04/04/2024 | Buy Now | 1071.17% | Morgan Stanley | Judah Frommer66% | → $13 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Mural Oncology (MURA) stock?
The latest price target for Mural Oncology (NASDAQ:MURA) was reported by HC Wainwright & Co. on March 26, 2025. The analyst firm set a price target for $6.00 expecting MURA to rise to within 12 months (a possible 440.54% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mural Oncology (MURA)?
The latest analyst rating for Mural Oncology (NASDAQ:MURA) was provided by HC Wainwright & Co., and Mural Oncology maintained their buy rating.
When was the last upgrade for Mural Oncology (MURA)?
There is no last upgrade for Mural Oncology
When was the last downgrade for Mural Oncology (MURA)?
The last downgrade for Mural Oncology PLC happened on March 25, 2025 when Jones Trading changed their price target from N/A to N/A for Mural Oncology PLC.
When is the next analyst rating going to be posted or updated for Mural Oncology (MURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mural Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mural Oncology was filed on March 26, 2025 so you should expect the next rating to be made available sometime around March 26, 2026.
Is the Analyst Rating Mural Oncology (MURA) correct?
While ratings are subjective and will change, the latest Mural Oncology (MURA) rating was a maintained with a price target of $18.00 to $6.00. The current price Mural Oncology (MURA) is trading at is $1.11, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.